LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Dasatinib
0.056667
 27.49 27.76 1402 1723 0.8136 0.9319
MN20160318_Q01
E11
MCF 10A-H2B-mCherry Dasatinib
0.056667
 27.49 27.76 1574 1723 0.9135 0.9698
MN20160318_Q01
E11
MCF 10A-H2B-mCherry Dasatinib
0.056667
 29.19 27.76 23 1863 0.0123 -0.0305
MN20160318_Q01
D14
MCF 10A-H2B-mCherry Dasatinib
0.056667
 29.19 27.76 1470 1863 0.7890 0.9234
MN20160318_Q01
D14
MCF 10A-H2B-mCherry Dasatinib
0.056667
 29.19 27.76 1501 1863 0.8056 0.9300
MN20160318_Q01
E11
MCF 10A-H2B-mCherry Dasatinib
0.056667
 29.19 27.76 1649 1863 0.8851 0.9602
MN20160318_Q01
E11
MCF 10A-H2B-mCherry Dasatinib
0.056667
 30.90 27.76 35 2032 0.0172 0.0381
MN20160318_Q01
D14
MCF 10A-H2B-mCherry Dasatinib
0.056667
 30.90 27.76 1575 2032 0.7750 0.9194
MN20160318_Q01
D14
MCF 10A-H2B-mCherry Dasatinib
0.056667
 30.90 27.76 1613 2032 0.7937 0.9268
MN20160318_Q01
E11
MCF 10A-H2B-mCherry Dasatinib
0.056667
 30.90 27.76 1758 2032 0.8650 0.9537
MN20160318_Q01
E11
MCF 10A-H2B-mCherry Dasatinib
0.056667
 32.60 27.76 36 2235 0.0161 0.0419
MN20160318_Q01
D14
MCF 10A-H2B-mCherry Dasatinib
0.056667
 32.60 27.76 1688 2235 0.7550 0.9132
MN20160318_Q01
D14
MCF 10A-H2B-mCherry Dasatinib
0.056667
 32.60 27.76 1746 2235 0.7809 0.9234
MN20160318_Q01
E11
MCF 10A-H2B-mCherry Dasatinib
0.056667
 32.60 27.76 1882 2235 0.8417 0.9463
MN20160318_Q01
E11
MCF 10A-H2B-mCherry Dasatinib
0.056667
 34.30 27.76 39 2449 0.0159 0.0540
MN20160318_Q01
D14
MCF 10A-H2B-mCherry Dasatinib
0.056667
 34.30 27.76 1767 2449 0.7213 0.9014
MN20160318_Q01
D14
MCF 10A-H2B-mCherry Dasatinib
0.056667
 34.30 27.76 1873 2449 0.7646 0.9186
MN20160318_Q01
E11
MCF 10A-H2B-mCherry Dasatinib
0.056667
 34.30 27.76 2001 2449 0.8168 0.9384
MN20160318_Q01
E11
MCF 10A-H2B-mCherry Dasatinib
0.056667
 36.01 27.76 33 2662 0.0124 0.0266
MN20160318_Q01
D14
MCF 10A-H2B-mCherry Dasatinib
0.056667
 36.01 27.76 1918 2662 0.7203 0.9028
MN20160318_Q01
D14
MCF 10A-H2B-mCherry Dasatinib
0.056667
 36.01 27.76 1993 2662 0.7484 0.9139
MN20160318_Q01
E11
MCF 10A-H2B-mCherry Dasatinib
0.056667
 36.01 27.76 2098 2662 0.7879 0.9289
MN20160318_Q01
E11
MCF 10A-H2B-mCherry Dasatinib
0.056667
 37.71 27.76 40 2877 0.0139 0.0561
MN20160318_Q01
D14
MCF 10A-H2B-mCherry Dasatinib
0.056667
 37.71 27.76 2047 2877 0.7114 0.9008
MN20160318_Q01
D14
MCF 10A-H2B-mCherry Dasatinib
0.056667
 37.71 27.76 2120 2877 0.7367 0.9108
MN20160318_Q01
E11